T1	Participants 76 122	patients with or without nodal micrometastases
T2	Participants 278 318	patients with non-small cell lung cancer
T3	Participants 740 772	Lymph nodes from patients (n=94)
T4	Participants 1530 1579	tumor cells was detected in 21 out of 94 patients
T5	Participants 2063 2136	survival in patients without an early locoregional spread of cancer cells
T6	Participants 2201 2213	all patients
